Literature DB >> 8772438

Adrenergic, dopaminergic, and muscarinic receptor stimulation leads to PKA phosphorylation of Na-K-ATPase.

P Beguin1, A Beggah, S Cotecchia, K Geering.   

Abstract

Na-K-adenosinetriphosphatase (Na-K-ATPase) is a potential target for phosphorylation by protein kinase A (PKA) and C (PKC). We have investigated whether the Na-K-ATPase alpha-subunit becomes phosphorylated at its PKA or PKC phosphorylation sites upon stimulation of G protein-coupled receptors primarily linked either to the PKA or the PKC pathway. COS-7 cells, transiently or stably expressing Bufo marinus Na-K-ATPase wild-type alpha- or mutant alpha-subunits affected in its PKA or PKC phosphorylation site, were transfected with recombinant DNA encoding beta 2- or alpha 1-adrenergic (AR), dopaminergic (D1A-R), or muscarinic cholinergic (M1-AChR) receptor subspecies. Agonist stimulation of beta 2-AR or D1A-R led to phosphorylation of the wild-type alpha-subunit, as well as the PKC mutant, but not of the PKA mutant, indicating that these receptors can phosphorylate the Na-K-ATPase via PKA activation. Surprisingly, stimulation of the alpha 1B-AR, alpha 1C-AR, and M1-AChR also increased the phosphorylation of the wild-type alpha-subunit and its PKC mutant but not of its PKA mutant. Thus the phosphorylation induced by these primarily phospholipase C-linked receptors seems mainly mediated by PKA activation. These data indicate that the Na-K-ATPase alpha-subunit can act as an ultimate target for PKA phosphorylation in a cascade starting with agonist-receptor interaction and leading finally to a phosphorylation-mediated regulation of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772438     DOI: 10.1152/ajpcell.1996.270.1.C131

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Repeated ischaemic isometric exercise increases muscle fibre conduction velocity in humans: involvement of Na(+)-K(+)-ATPase.

Authors:  G A Rongen; J P van Dijk; E E van Ginneken; D F Stegeman; P Smits; M J Zwarts
Journal:  J Physiol       Date:  2002-05-01       Impact factor: 5.182

2.  Is phosphorylation of the alpha1 subunit at Ser-16 involved in the control of Na,K-ATPase activity by phorbol ester-activated protein kinase C?

Authors:  E Féraille; P Béguin; M L Carranza; S Gonin; M Rousselot; P Y Martin; H Favre; K Geering
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

3.  The muscarinic M1 receptor positive allosteric modulator PQCA improves cognitive measures in rat, cynomolgus macaque, and rhesus macaque.

Authors:  Jason M Uslaner; Donnie Eddins; Vanita Puri; Christopher E Cannon; Jane Sutcliffe; Chan Sing Chew; Michelle Pearson; Jeffrey A Vivian; Ronald K Chang; William J Ray; Scott D Kuduk; Marion Wittmann
Journal:  Psychopharmacology (Berl)       Date:  2012-07-24       Impact factor: 4.530

4.  Dopamine D₁-like receptors regulate the α₁A-adrenergic receptor in human renal proximal tubule cells and D₁-like dopamine receptor knockout mice.

Authors:  Riley Charles Ennis; Laureano D Asico; Ines Armando; Jian Yang; Jun B Feranil; Julie A Jurgens; Crisanto S Escano; Peiying Yu; Xiaoyan Wang; David R Sibley; Pedro A Jose; Van Anthony M Villar
Journal:  Am J Physiol Renal Physiol       Date:  2014-10-22

5.  Subunit-dependent modulation of kainate receptors by muscarinic acetylcholine receptors.

Authors:  Morris Benveniste; Jennifer Wilhelm; Raymond J Dingledine; David D Mott
Journal:  Brain Res       Date:  2010-07-23       Impact factor: 3.252

6.  Na(+)-K+ pump cycle during beta-adrenergic stimulation of adult rat cardiac myocytes.

Authors:  M Dobretsov; S L Hastings; J R Stimers
Journal:  J Physiol       Date:  1998-03-01       Impact factor: 5.182

7.  Improved cognition without adverse effects: novel M1 muscarinic potentiator compares favorably to donepezil and xanomeline in rhesus monkey.

Authors:  Joshua D Vardigan; Christopher E Cannon; Vanita Puri; Mandy Dancho; AmyJo Koser; Marion Wittmann; Scott D Kuduk; John J Renger; Jason M Uslaner
Journal:  Psychopharmacology (Berl)       Date:  2014-12-10       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.